Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Lecia V. Sequist
ResearcherPublications, citations & collaboration network
Lecia V. Sequist is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 816 works, 78,105 citations, an h-index of 119 and an i10-index of 331.
816
Works
78,105
Citations
119
h-index
331
i10-index
How has Lecia V. Sequist's publication output changed over time?
ScholarIQpublication output · 2007–2021
Output grew0% over the shown period — from 1 works in 2007 to 1 in 2021.
1
1
2
1
1
2
1
1
1
1
2007200820102011201220132014201520162021
What are the most-cited papers on Lecia V. Sequist?
ScholarIQmost cited works
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge, Alice T. Shaw, Benjamin Solomon, Robert G. Maki, Sai‐Hong Ignatius Ou, Bruce J. Dezube, Pasi A. Jänne, Daniel B. Costa, Marileila Varella‐Garcia, Woo Ho Kim, Thomas J. Lynch, Panos Fidias, Hannah Stubbs, Jeffrey A. Engelman, Lecia V. Sequist, Weiwei Tan, Leena Gandhi, Mari Mino–Kenudson, Greg C. G. Wei, S. Martin Shreeve, Mark J. Ratain, Jeffrey Settleman, James G. Christensen, Daniel A. Haber, Keith D. Wilner, Ravi Salgia, Geoffrey I. Shapiro, Jeffrey W. Clark, A. John Iafrate
New England Journal of Medicine. 20104,513 Citations
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata, Subba R. Digumarthy, Alexa B. Turke, Panos Fidias, Kristin Bergethon, Alice T. Shaw, Scott Gettinger, Arjola K. Cosper, Sara Akhavanfard, Rebecca S. Heist, Jennifer S. Temel, James G. Christensen, John C. Wain, Thomas J. Lynch, Kathy Vernovsky, Eugene J. Mark, Michael Lanuti, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman
S24207032. 20113,582 CitationsOPEN ACCESS
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath, Lecia V. Sequist, Shyamala Maheswaran, Daphne W. Bell, Daniel Irimia, Lindsey Ulkus, Matthew R. Smith, Eunice L. Kwak, Subba R. Digumarthy, Alona Muzikansky, Paula D. Ryan, Ulysses J. Balis, Ronald G. Tompkins, Daniel A. Haber, Mehmet Toner
Nature. 20073,549 CitationsOPEN ACCESS
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
Lecia V. Sequist, James Chih‐Hsin Yang, Nobuyuki Yamamoto, Kenneth J. O’Byrne, Vera Hirsh, Tony Mok, Sarayut Lucien Geater, С. В. Орлов, Chun‐Ming Tsai, Michael Boyer, Wu‐Chou Su, Jaafar Bennouna, Terufumi Kato, В. А. Горбунова, Ki Hyeong Lee, Riyaz Shah, Dan Massey, Victoria Zazulina, Mehdi Shahidi, Martin Schüler
Journal of Clinical Oncology. 20133,210 Citations
Lung cancer
Alesha Thai, Benjamin Solomon, Lecia V. Sequist, Justin F. Gainor, Rebecca S. Heist
The Lancet. 20212,586 Citations
Related on ScholarIQ
Harvard University
Institution
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Paper
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Paper
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Paper
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
Paper
Lung cancer
Paper